Company Monitoring Page for AbbVie

job ratings for AbbVie

08/19/18
industry:
Big Pharma
job title:
Sales rep
company:
AbbVie
job rating:
1
My manager is having an affair with a rep in my same district. The favortism is off the charts!
08/17/18
industry:
Bio pharmaceutical Industry
job title:
Executive
company:
AbbVie
job rating:
1
Abusive managers. I have never seen management behaviors that I have seen at AbbVie. Even at the highest levels. No willingness to hear different perspectives. I feel dumber every day I work here. Toxic.
08/13/18
industry:
Big Pharma
job title:
Sales rep
company:
AbbVie
job rating:
1
Co-workers are bipolar.
08/12/18
industry:
pharmaceutical
job title:
Sales re seattle territory
company:
AbbVie
job rating:
1
Management in the NW sucks!
12/21/17
industry:
Big Pharma Sales
job title:
Sales rep
company:
AbbVie
job rating:
1
Toxic environment
12/01/17
industry:
Big Pharma
job title:
Sales rep
company:
AbbVie
job rating:
1
I hate the products, management, and compensation. Managers are abusive, especially in the NW.
12/01/17
industry:
Pharaceutical
job title:
Sales rep
company:
AbbVie
job rating:
1
I work at Abbvie metabolics. It sucks!
07/18/17
industry:
Primary care
job title:
Sales rep
company:
AbbVie
job rating:
1
Management and products suck in the NW.
04/12/17
industry:
Big Pharma
job title:
Sales rep
company:
AbbVie
job rating:
1
I hate my job!
04/12/17
industry:
Big Pharma
job title:
Sales rep
company:
AbbVie
job rating:
1
I haven't gotten a raise in years!
04/12/17
industry:
Big Pharma
job title:
Sales rep
company:
AbbVie
job rating:
1
The management in the NW sucks!
04/05/17
industry:
Bio pharmaceutical Industry
job title:
Sales rep
company:
AbbVie
job rating:
1
I work at Abbvie, need I say more.

Pages

latest headlines for company on cafepharma

AbbVie taps T-cell engager tech from EvolveImmune to build next-gen cancer biologics
First Word Pharma
Thu, 10/31/24 - 09:39 am
Tags:
AbbVie, EvolveImmune, T-cell engager
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
Investors Business Daily
Wed, 10/30/24 - 08:50 pm
Tags:
AbbVie, earnings, Humira, Skyrizi
AbbVie doubles down on Alzheimer’s with $1.4B Aliada buy
BioSpace
Mon, 10/28/24 - 11:41 am
Tags:
AbbVie, M&A, Alzheimer's disease, Aliada Therapeutics
AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator
Fierce Biotech
Fri, 10/25/24 - 11:37 am
Tags:
AbbVie, Vraylar, Gedeon Richter, drug discovery
After rejections, AbbVie secures approval for Parkinson’s drug
BioPharma Dive
Thu, 10/17/24 - 08:52 pm
Tags:
AbbVie, Parkinson's Disease, Vyalev, FDA
Skyrizi notches top pharma, Rx brand spot for Q3 2024
Medical Marketing and Media
Mon, 10/7/24 - 09:52 pm
Tags:
AbbVie, Skyrizi, Crohn's Disease, psoriatic arthritis
AbbVie cuts 2024 profit forecast citing R&D expenses
Reuters
Thu, 10/3/24 - 09:26 pm
Tags:
AbbVie, R&D
Louisiana district court upholds state 340B contract pharmacy law
American Hospital Association
Wed, 10/2/24 - 10:01 pm
Tags:
legal, Louisiana, 340B, contract pharmacies, AbbVie, AstraZeneca, PhRMA
EU withdraws marketing authorisation for Abbvie's hepatitis C drug
Reuters
Wed, 10/2/24 - 11:16 am
Tags:
AbbVie, Europe, Exviera, hepatitis C
Blue Shield of California bypasses PBMs to slash Humira prices by 90%
Pharmaphorum
Wed, 10/2/24 - 09:37 am
Tags:
Blue Shield, California, PBMs, AbbVie, Humira
AbbVie seeks FDA approval for non-small cell lung cancer treatment
Pharmaceutical Business Review
Mon, 09/30/24 - 09:45 am
Tags:
AbbVie, FDA, Teliso-V, non-small cell lung cancer
AbbVie’s $8.7bn Parkinson’s disease drug shines in Phase III trial
Clinical Trials Arena
Mon, 09/30/24 - 09:15 am
Tags:
AbbVie, Parkinson's Disease, tavapadon, clinical trials
AbbVie's Parkinson's disease drug meets main goal in late-stage trial
Reuters
Thu, 09/26/24 - 11:21 am
Tags:
AbbVie, Parkinson's Disease, clinical trials, tavapadon
AbbVie’s RINVOQ shows promise in two Phase III atopic dermatitis trials
Clinical Trials Arena
Thu, 09/26/24 - 11:14 am
Tags:
AbbVie, Rinvoq, atopic dermatitis, clinical trials
New migraine drugs less effective than previous generation of triptan meds: BMJ study
Fierce Pharma
Thu, 09/19/24 - 09:29 pm
Tags:
migraines, BMJ, Pfizer, Nurtec, AbbVie, Ubrelvy, Eli Lilly, Reyvow
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
AOL
Tue, 09/10/24 - 04:33 pm
Tags:
AbbVie, Humira, biosimilars, Unitedhealth Group, OptumRx
AbbVie sues rival BeiGene over alleged theft of cancer therapy secrets
Reuters
Tue, 09/10/24 - 09:15 am
Tags:
AbbVie, BeiGene, trade secrets, legal
AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study
Fierce Pharma
Thu, 08/29/24 - 06:06 pm
Tags:
AbbVie, Ubrelvy, migraines, clinical trials
Cigna to remove AbbVie's Humira from some drug reimbursement lists next year
Reuters
Mon, 08/26/24 - 10:14 pm
Tags:
AbbVie, Humira, biosimilars, Cigna, reimbursement
BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings
Pharma Voice
Mon, 08/19/24 - 09:58 am
Tags:
Bristol Myers Squibb, KarXT, FDA, schizophrenia, AbbVie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.